Lothar Germeroth
Directeur Général chez Juno Therapeutics GmbH
Profil
Lothar Germeroth is the founder of Repairon GmbH, which was founded in 2014.
He currently holds the position of Executive Chairman-Supervisory Board & CEO at Repairon GmbH.
Dr. Germeroth is also the Co-Managing Director at Juno Therapeutics GmbH.
In the past, he has worked as the Chief Executive Officer at IBA GmbH and as a Principal at Cytos Biotechnology AG.
Dr. Germeroth has an undergraduate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main and a doctorate degree from Max-Planck-Institute for Molecular Genetics.
Postes actifs de Lothar Germeroth
| Sociétés | Poste | Début |
|---|---|---|
Juno Therapeutics GmbH
 Juno Therapeutics GmbH BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Juno Therapeutics GmbH is a German company that researches and develops cellular therapies. The company is based in Munich, Germany. The CEOs of the company are David Walter Pignolet, Lothar Germeroth. Juno Therapeutics was acquired by Juno Therapeutics, Inc., part of Bristol Myers Squibb Co. from March 07, 2018 on May 11, 2015 for $232.80 million. | Directeur Général | - |
Repairon GmbH
 Repairon GmbH Repairon GmbH engages in the development, manufacture, and commercialization of induced pluripotent stem cell based tissues for organ repair. It offers therapeutic products such as tissue patches and pouches for the treatment of patients with heart failure caused by ischemic and dilatative cardiomyopathies. The company was founded by Wolfram Zimmermann in 2004 and is headquartered in Goettingen, Germany. | Directeur Général | 15/09/2023 |
Anciens postes connus de Lothar Germeroth
| Sociétés | Poste | Fin |
|---|---|---|
Cytos Biotechnology AG
 Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland. | Corporate Officer/Principal | - |
IBA GmbH
 IBA GmbH Medical/Nursing ServicesHealth Services IBA GmbH provides product and service solutions for life science research. Its product and service portfolio includes cell selection and expansion, cloning, transfection, recombinant protein production and assays to nucleic acid custom services. The company was founded in 1999 and is headquartered in Göttingen, Germany. | Directeur Général | - |
Formation de Lothar Germeroth
| Max-Planck-Institute for Molecular Genetics | Doctorate Degree |
| Johann Wolfgang Goethe-Universität Frankfurt am Main | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
IBA GmbH
IBA GmbH Medical/Nursing ServicesHealth Services IBA GmbH provides product and service solutions for life science research. Its product and service portfolio includes cell selection and expansion, cloning, transfection, recombinant protein production and assays to nucleic acid custom services. The company was founded in 1999 and is headquartered in Göttingen, Germany. | Health Services |
Cytos Biotechnology AG
Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland. | Commercial Services |
Juno Therapeutics GmbH
Juno Therapeutics GmbH BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Juno Therapeutics GmbH is a German company that researches and develops cellular therapies. The company is based in Munich, Germany. The CEOs of the company are David Walter Pignolet, Lothar Germeroth. Juno Therapeutics was acquired by Juno Therapeutics, Inc., part of Bristol Myers Squibb Co. from March 07, 2018 on May 11, 2015 for $232.80 million. | Health Technology |
Repairon GmbH
Repairon GmbH Repairon GmbH engages in the development, manufacture, and commercialization of induced pluripotent stem cell based tissues for organ repair. It offers therapeutic products such as tissue patches and pouches for the treatment of patients with heart failure caused by ischemic and dilatative cardiomyopathies. The company was founded by Wolfram Zimmermann in 2004 and is headquartered in Goettingen, Germany. |
